Systemic chemotherapy combined with anti-epidermal growth factor receptor antibody therapy for RAS wild-type appendiceal signet-ring cell carcinoma: a series of three cases | Zendy

Suguru Hirose | Zendy; Chiaki Enami | Zendy; Natsumi Kawamatsu | Zendy; Yoshimi ITO | Zendy; Tsubasa Onoda | Zendy; Yutaro Sugiyama | Zendy; Hirosumi Suzuki | Zendy; Miho Nagafuchi | Zendy; Takafumi Ikeda | Zendy; Yusuke Niisato | Zendy; Takeshi Yamada | Zendy; Yoshiyuki Yamamoto | Zendy; Toshikazu Moriwaki | Zendy; Hideo Suzuki | Zendy

Open Access

Systemic chemotherapy combined with anti-epidermal growth factor receptor antibody therapy for RAS wild-type appendiceal signet-ring cell carcinoma: a series of three cases

Author(s) -

Suguru Hirose,

Chiaki Enami,

Natsumi Kawamatsu,

Yoshimi ITO,

Tsubasa Onoda,

Yutaro Sugiyama,

Hirosumi Suzuki,

Miho Nagafuchi,

Takafumi Ikeda,

Yusuke Niisato,

Takeshi Yamada,

Yoshiyuki Yamamoto,

Toshikazu Moriwaki,

Hideo Suzuki

Publication year - 2021

Publication title -

international cancer conference journal

Language(s) - English

Resource type - Journals

ISSN - 2192-3183

DOI - 10.1007/s13691-021-00507-w

Subject(s) - folfox , folfiri , cetuximab , panitumumab , chemotherapy , epidermal growth factor receptor , medicine , oncology , signet ring cell , epidermal growth factor , colorectal cancer , signet ring cell carcinoma , cancer research , gastroenterology , cancer , oxaliplatin , adenocarcinoma , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog